Smoking, but not malnutrition, influences promoter-specific DNA methylation of the proopiomelanocortin gene in patients with and without anorexia nervosa

Canadian Journal of Psychiatry

Volumn 57, Issue 3, 2012, Pages 168-176

  Ehrlich, Stefan ^a,b,c   Walton, Esther ^d   Roffman, Joshua L ^c   Weiss, Deike ^b   Puls, Imke ^b   Doehler, Nico ^b   Burghardt, Roland ^b   Lehmkuhl, Ulrike ^b   Hillemacher, Thomas ^e   Muschler, Marc ^e   Frieling, Helge ^e,f  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Anorexia nervosa; CpG island; DNA methylation; Malnutrition; Proopiomelanocortin; Smoking

Indexed keywords

ALPHA INTERMEDIN; BISULFITE; CORTICOTROPIN; DNA; FOLIC ACID; LEPTIN; PROOPIOMELANOCORTIN;

ADOLESCENT; ADULT; ANOREXIA NERVOSA; ARTICLE; BODY MASS; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; ENVIRONMENTAL FACTOR; EPIGENETICS; FEEDING; FEMALE; FOLIC ACID BLOOD LEVEL; FOOD INTAKE; GENETIC ASSOCIATION; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALNUTRITION; NUTRITIONAL STATUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PILOT STUDY; PROMOTER REGION; SMOKING; STRESS; UNDERWEIGHT;

EID: 84865356701     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371205700306     Document Type: Article

References (74)

1. Fan J, Zhang C, Gu N, et al. Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis. Biol Psychiatry. 2005;57(2):139-144.
2. Kato T. Molecular genetics of bipolar disorder and depression. Psychiatry Clin Neurosci. 2007;61(1):3-19.
3. Ziegler A, Hebebrand J, Görg T, et al. Further lack of association between the 5-HT2A gene promoter polymorphism and susceptibility to eating disorders and a meta-analysis pertaining to anorexia nervosa. Mol Psychiatry. 1999;4(5):410-412.
4. Abdolmaleky HM, Cheng K-hung, Faraone SV, et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet. 2006;15(21):3132-3145.
5. Abdolmaleky HM, Smith CL, Zhou JR, et al. Epigenetic alterations of the dopaminergic system in major psychiatric disorders. Methods Mol Biol. 2008;448:187-212.
6. Handy DE, Castro R, Loscalzo J. Epigenetic modifications: basic mechanisms and role in cardiovascular disease. Circulation. 2011;123(19):2145- 2156.
7. Rodenhiser D, Mann M. Epigenetics and human disease: translating basic biology into clinical applications. CMAJ. 2006;174(3):341-348.
8. Biliya S, Bulla LA Jr. Genomic imprinting: the influence of differential methylation in the two sexes. Exp Biol Med (Maywood). 2010;235(2):139-147.
9. Weaver ICG, Cervoni N, Champagne FA, et al. Epigenetic programming by maternal behavior. Nat Neurosci. 2004;7(8):847-854.
10. Weaver ICG, Champagne FA, Brown SE, et al. Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. J Neurosci. 2005;25(47):11045-11054.
11. Friso S, Choi SW, Girelli D, et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci U S A. 2002;99(8):5606-5611.
12. Bleich S, Lenz B, Ziegenbein M, et al. Epigenetic DNA hypermethylation of the HERP gene promoter induces downregulation of its mRNA expression in patients with alcohol dependence. Alcohol Clin Exp Res. 2006;30(4):587-591.
13. Bönsch D, Lenz B, Reulbach U, et al. Homocysteine associated genomic DNA hypermethylation in patients with chronic alcoholism. J Neural Transm. 2004;111(12):1611-1616.
14. Hillemacher T, Frieling H, Moskau S, et al. Global DNA methylation is influenced by smoking behaviour. Eur Neuropsychopharmacol. 2008;18(4):295-298.
15. Launay JM, Del Pino M, Chironi G, et al. Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation. PLoS One. 2009;4(11):e7959.
16. Liu J, Morgan M, Hutchison K, et al. A study of the influence of sex on genome wide methylation. PLoS One. 2010;5(4):e10028.
17. Philibert RA, Beach SRH, Gunter TD, et al. The effect of smoking on MAOA promoter methylation in DNA prepared from lymphoblasts and whole blood. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(2):619-628.
18. Breitling LP, Yang R, Korn B, et al. Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet. 2011;88(4):450-457.
19. Brait M, Ford JG, Papaiahgari S, et al. Association between lifestyle factors and CpG island methylation in a cancer-free population. Cancer Epidemiol Biomarkers Prev. 2009;18(11):2984-2991.
20. 12 in genomic stability of human cells. Mutat Res. 2001;475(1-2):57-67.
21. Burdge GC, Lillycrop KA. Nutrition, epigenetics, and developmental plasticity: implications for understanding human disease. Annu Rev Nutr. 2010;30:315-339.
22. Wainfan E, Dizik M, Stender M, et al. Rapid appearance of hypomethylated DNA in livers of rats fed cancer-promoting, methyl-deficient diets. Cancer Res. 1989;49(15):4094-4097.
23. Frieling H, Gozner A, Römer KD, et al. Global DNA hypomethylation and DNA hypermethylation of the alpha synuclein promoter in females with anorexia nervosa. Mol Psychiatry. 2007;12(3):229-230.
24. Ehrlich S, Weiss D, Burghardt R, et al. Promoter specific DNA methylation and gene expression of POMC in acutely underweight and recovered patients with anorexia nervosa. J Psychiatr Res. 2010;44(13):827-833.
25. Cutuli M, Cristiani S, Lipton JM, et al. Antimicrobial effects of alpha- MSH peptides. J Leukoc Biol. 2000;67(2):233-239.
26. Smith AI, Funder JW. Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr Rev. 1988;9(1):159-179.
27. Barsh GS, Schwartz MW. Genetic approaches to studying energy balance: perception and integration. Nat Rev Genet. 2002;3(8):589-600.
28. Krieger DT, Yamaguchi H, Liotta AS. Human plasma ACTH, lipotropin, and endorphin. Adv Biochem Psychopharmacol. 1981;28:541-556.
29. Woods SC, Seeley RJ, Porte D Jr, et al. Signals that regulate food intake and energy homeostasis. Science. 1998;280(5368):1378-1383.
30. Bicknell AB. The tissue-specific processing of pro-opiomelanocortin. J Neuroendocrinol. 2008;20(6):692-699.
31. Chen AS, Metzger JM, Trumbauer ME, et al. Role of the melanocortin-4 receptor in metabolic rate and food intake in mice. Transgenic Res. 2000;9(2):145-154.
32. Chen AS, Marsh DJ, Trumbauer ME, et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet. 2000;26(1):97-102.
33. Huszar D, Lynch CA, Fairchild-Huntress V, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 1997;88(1):131-141.
34. Wikberg JE, Muceniece R, Mandrika I, et al. New aspects on the melanocortins and their receptors. Pharmacol Res. 2000;42(5):393-420.
35. Kageyama K, Suda T. Regulatory mechanisms underlying corticotropin- releasing factor gene expression in the hypothalamus. Endocr J. 2009;56(3):335-344.
36. Krebs MO, Bellon A, Mainguy G, et al. One-carbon metabolism and schizophrenia: current challenges and future directions. Trends Mol Med. 2009;15(12):562-570.
37. Frieling H, Römer KD, Scholz S, et al. Epigenetic dysregulation of dopaminergic genes in eating disorders. Int J Eat Disord. 2010;43(7):577-583.
38. Castro J, Deulofeu R, Gila A, et al. Persistence of nutritional deficiencies after short-term weight recovery in adolescents with anorexia nervosa. Int J Eat Disord. 2004;35(2):169-178.
39. Muschler MA, Hillemacher T, Kraus C, et al. DNA methylation of the POMC gene promoter is associated with craving in alcohol dependence. J Neural Transm. 2010;117(4):513-519.
40. Newell-Price J. Proopiomelanocortin gene expression and DNA methylation: implications for Cushing's syndrome and beyond. J Endocrinol. 2003;177(3):365-372.
41. Zhang F, Chen Y, Heiman M, et al. Leptin: structure, function and biology. Vitam Horm. 2005;71:345-372.
42. Hebebrand J, Muller TD, Holtkamp K, et al. The role of leptin in anorexia nervosa: clinical implications. Mol Psychiatry. 2007;12(1):23-35.
43. Kromeyer-Hauschild K, Wabitsch M, Kunze D, et al. Perzentile für den Body-mass-Index für das Kindes-und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschrift Kinderheilkunde. 2001;149(8):807-818. German.
44. Fichter M, Quadflieg N. SIAB. Strukturiertes Inventar für Anorektische und Bulimische Essstörungen nach DSM-IV und ICD-10. Bern (CH): Huber; 1999.
45. Rathner G, Waldherr K. Eating Disorder Inventory-2. Eine deutschsprachige Validierung mit Normen für weibliche und männliche Jugendliche. Z Klin Psychol, Psychiatr Psychother. 1997;45:157-182. German.
46. Lewin J, Schmitt AO, Adorján P, et al. Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics. 2004;20(17):3005-3012.
47. Cartharius K, Frech K, Grote K, et al. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics. 2005;21(13):2933-2942.
48. Wilhelm J, Müller E, de Zwaan M, et al. Elevation of homocysteine levels is only partially reversed after therapy in females with eating disorders. J Neural Transm. 2010;117(4):521-527.
49. Frieling H, Römer K, Röschke B, et al. Homocysteine plasma levels are elevated in females with anorexia nervosa. J Neural Transm. 2005;112(7):979-985.
50. Jhaveri MS, Wagner C, Trepel JB. Impact of extracellular folate levels on global gene expression. Mol Pharmacol. 2001;60(6):1288-1295.
51. Pizzolo F, Blom HJ, Choi SW, et al. Folic acid effects on s-adenosylmethionine, s-adenosylhomocysteine, and DNA methylation in patients with intermediate hyperhomocysteinemia. J Am Coll Nutr. 2011;30(1):11-18.
52. van den Donk M, van Engeland M, Pellis L, et al. Dietary folate intake in combination with MTHFR C677T genotype and promoter methylation of tumor suppressor and DNA repair genes in sporadic colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2007;16(2):327-333.
53. van Engeland M, Weijenberg MP, Roemen GMJM, et al. Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. Cancer Res. 2003;63(12):3133-3137.
54. Frieling H, Bleich S, Otten J, et al. Epigenetic downregulation of atrial natriuretic peptide but not vasopressin mRNA expression in females with eating disorders is related to impulsivity. Neuropsychopharmacology. 2008;33(11):2605-2609.
55. Frieling H, Albrecht H, Jedtberg S, et al. Elevated cannabinoid 1 receptor mRNA is linked to eating disorder related behavior and attitudes in females with eating disorders. Psychoneuroendocrinology. 2009;34(4):620-624.
56. Marsit CJ, McClean MD, Furniss CS, et al. Epigenetic inactivation of the SFRP genes is associated with drinking, smoking and HPV in head and neck squamous cell carcinoma. Int J Cancer. 2006;119(8):1761-1766.
57. Soma T, Kaganoi J, Kawabe A, et al. Nicotine induces the fragile histidine triad methylation in human esophageal squamous epithelial cells. Int J Cancer. 2006;119(5):1023-1027.
58. Dammann R, Strunnikova M, Schagdarsurengin U, et al. CpG island methylation and expression of tumour-associated genes in lung carcinoma. Eur J Cancer. 2005;41(8):1223-1236.
59. Kikuchi S, Yamada D, Fukami T, et al. Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma. Cancer. 2006;106(8):1751-1758.
60. Liu Y, Gao W, Siegfried JM, et al. Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers. BMC Cancer. 2007;7:74.
61. von Zeidler SV, Miracca EC, Nagai MA, et al. Hypermethylation of the p16 gene in normal oral mucosa of smokers. Int J Mol Med. 2004;14(5):807-811.
62. Yanagawa N, Tamura G, Oizumi H, et al. Frequent epigenetic silencing of the p16 gene in non-small cell lung cancers of tobacco smokers. Jpn J Cancer Res. 2002;93(10):1107-1113.
63. Breton CV, Byun H-M, Wenten M, et al. Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am J Respir Crit Care Med. 2009;180(5):462-467.
64. Ehrlich S, Franke L, Schott R, et al. Platelet monoamine oxidase activity in underweight and weight-recovered females with anorexia nervosa. Pharmacopsychiatry. 2008;41(6):226-231.
65. Chiolero A, Faeh D, Paccaud F, et al. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr. 2008;87(4):801-809.
66. Filozof C, Fernández Pinilla MC, Fernández-Cruz A. Smoking cessation and weight gain. Obes Rev. 2004;5(2):95-103.
67. Rohleder N, Kirschbaum C. The hypothalamic-pituitaryadrenal (HPA) axis in habitual smokers. Int J Psychophysiol. 2006;59(3):236-243.
68. McGowan PO, Sasaki A, D'Alessio AC, et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci. 2009;12(3):342-348.
69. Murgatroyd C, Patchev AV, Wu Y, et al. Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat Neurosci. 2009;12(12):1559-1566.
70. al' Absi M. Hypothalamic-pituitary-adrenocortical responses to psychological stress and risk for smoking relapse. Int J Psychophysiol. 2006;59(3):218-227.
71. Connan F, Campbell IC, Katzman M, et al. A neurodevelopmental model for anorexia nervosa. Physiol Behav. 2003;79(1):13-24.
72. Ehrlich S, Burghardt R, Schneider N, et al. The role of leptin and cortisol in hyperactivity in patients with acute and weightrecovered anorexia nervosa. Prog Neuro-Psychopharmacol Biol Psychiatry. 2009;33(4):658-662.
73. Blalock JE. Proopiomelanocortin and the immune-neuroendocrine connection. Ann N Y Acad Sci. 1999;885:161-172.
74. Raffin-Sanson ML, de Keyzer Y, Bertagna X. Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. Eur J Endocrinol. 2003;149(2):79-90.